In our study, we examined the expression of VEGF and Bcl-2 in the tissue of 216 patients with locally advanced and metastatic NSCLC, association of IHC expression and clinicopathologial features, as well as correlation of IHC expression. This evidence concerns the gene BCL2 and non-small cell lung carcinoma.